TrialTrials2017

An optimized background regimen design to evaluate the contribution of levofloxacin to multidrug-resistant tuberculosis treatment regimens: study protocol for a randomized controlled trial.

Tara C Bouton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.